LADENBURG THALMANN FINANCIAL SERVICES INC. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 142 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$80,000
+17.6%
5,418
+5.9%
0.00%
Q3 2019$68,000
-1.4%
5,118
+21.5%
0.00%
Q2 2019$69,000
-42.0%
4,213
-39.4%
0.00%
-100.0%
Q1 2019$119,000
+70.0%
6,956
+37.2%
0.00%0.0%
Q4 2018$70,000
-50.0%
5,071
+4.3%
0.00%0.0%
Q3 2018$140,000
+68.7%
4,863
+23.6%
0.00%0.0%
Q2 2018$83,0000.0%3,9350.0%0.00%0.0%
Q1 2018$83,000
+48.2%
3,935
+35.7%
0.00%0.0%
Q4 2017$56,000
+107.4%
2,900
+163.6%
0.00%
Q3 2017$27,000
+1250.0%
1,100
+1000.0%
0.00%
Q2 2017$2,000
+100.0%
1000.0%0.00%
Q1 2017$1,0001000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders